MJS HEALTHCARE LIMITED

	Registered number
	02217463

	MJS HEALTHCARE LIMITED
	Unaudited Accounts
	for the year ended
	31 March 2025

MJS HEALTHCARE LIMITED Balance Sheet as at 31 March 2025
	Notes		2025 £		2024 £
Fixed assets
Intangible assets	3		25,943		28,791
Tangible assets	4		36,101		47,553
			62,044		76,344

Current assets
Stocks		194,251		248,961
Debtors		226,363		247,556
Cash at bank and in hand		57,152		100,220
		477,766		596,737

Creditors: amounts falling due within one year		(676,884)		(535,005)

Net current assets / (liabilities)			(199,118)		61,732

Total assets less current liabilities			(137,074)		138,076

Creditors: amounts falling due after more than one year			(5,833)		(15,833)

Provisions for liabilities			(6,287)		(14,753)

Total net assets (liabilities)			(149,194)		107,490

Capital and reserves
Called up share capital	5		5,000		5,000
Profit and loss account			(154,194)		102,490
Shareholders' funds			(149,194)		107,490

These accounts have been prepared and delivered in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

The directors have not delivered a copy of the company's Profit and Loss account as permitted by s444(5A) of the Companies Act 2006.

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Signed on behalf of the board of directors

...............................

Mr C Saggers

Director

Approved by the board on 3 December 2025

Company Number: 02217463 (a Private Company Limited by Shares registered in England and Wales)

Registered Office:

310-312 Dallow Road
Luton
Bedfordshire
LU1 1TD

1.	Accounting policies
	Basis of preparation of financial statements These financial statements have been prepared under the historic cost convention in accordance with the accounting policies set out below and with section 1A of FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland, and the Companies Act 2006. The presentation currency is sterling.

	Going concern basis
	Due to the negative impact of global events management is undertaking initiatives to mitigate and permanently reduce the fixed costs of the company. Having evaluated the proposed actions being taken the Director believes that the going concern basis is appropriate.

	Revenue recognition
	Revenue is measured at the fair value of the consideration received or receivable. Revenue is reduced for estimated customer returns, rebates and other similar allowances. Revenue from the sale of goods is recognised when goods are delivered and legal title has passed.

Tangible fixed assets depreciation policy

Tangible fixed assets are stated at cost less accumulated depreciation and impairment losses. Depreciation is provided, after taking account of any grants receivable, at rates calculated to write off the cost of fixed assets, less the estimated residual value, over their estimated useful lives.

Office equipment	25% Reducing Balance
Vehicles	25% Reducing Balance
Plant & machinery	25% Reducing Balance

	Intangible fixed assets
	Amortisation is provided on all intangible fixed assets at rates calculated to write off the assets over their expected useful economic life at annual rates as follows:- Patents - 10% straight line At each balance sheet date, the company reviews the carrying amount of its intangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss, if any. Where it is not possible to estimate the recoverable amount of the asset, the Company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Intangible fixed assets

Amortisation is provided on all intangible fixed assets at rates calculated to write off the assets over their expected useful economic life at annual rates as follows:-
Patents - 10% straight line

At each balance sheet date, the company reviews the carrying amount of its intangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss, if any. Where it is not possible to estimate the recoverable amount of the asset, the Company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

	Stocks
	Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell (net realisable value). Costs, which comprise direct production costs, are based on the method most appropriate to the type of inventory class, but usually on a first-in-first-out basis. Overheads are charged to profit or loss as incurred. Net realisable value is based on the estimated selling price less any estimated completion or selling costs. When stocks are sold, the carrying amount of those stocks is recognised as an expense in the period in which the related revenue is recognised. The amount of any write-down of stocks to net realisable value and all losses of stocks are recognised as an expense in the period in which the write-down or loss occurs. The amount of any reversal of any write-down of stocks is recognised as a reduction in the amount of stocks recognised as an expense in the period in which the reversal occurs.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell (net realisable value). Costs, which comprise direct production costs, are based on the method most appropriate to the type of inventory class, but usually on a first-in-first-out basis. Overheads are charged to profit or loss as incurred. Net realisable value is based on the estimated selling price less any estimated completion or selling costs.

When stocks are sold, the carrying amount of those stocks is recognised as an expense in the period in which the related revenue is recognised. The amount of any write-down of stocks to net realisable value and all losses of stocks are recognised as an expense in the period in which the write-down or loss occurs. The amount of any reversal of any write-down of stocks is recognised as a reduction in the amount of stocks recognised as an expense in the period in which the reversal occurs.

	Deferred taxation
	Taxation represents the sum of tax currently payable and deferred tax. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period. Deferred tax is recognised on all timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period.

Deferred taxation

Taxation represents the sum of tax currently payable and deferred tax.
The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

Deferred tax is recognised on all timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period.

	Research and development
	Expenditure on research and development is written off in the year in which it is incurred.

	Foreign currencies
	Transactions in currencies, other than the functional currency of the company, are recorded at the rate of exchange on the date the transaction occurred. Monetary items denominated in other currencies are translated at the rate prevailing at the end of the reporting period. All differences are taken to the profit and loss account.

	Leases and hire purchase contracts
	Assets obtained under hire purchase contracts and finance leases are capitalised as tangible assets and depreciated over their useful lives. Obligations under such agreements are included in creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to the profit and loss account so as to produce a constant periodic rate of charge on the net obligation outstanding in each period. Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged against profit on a straight line basis over the lease term.

Leases and hire purchase contracts

Assets obtained under hire purchase contracts and finance leases are capitalised as tangible assets and depreciated over their useful lives. Obligations under such agreements are included in creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to the profit and loss account so as to produce a constant periodic rate of charge on the net obligation outstanding in each period.
Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged against profit on a straight line basis over the lease term.

	Pensions
	Contributions in respect of the company's defined contribution pension schemes are charged to the profit and loss account for the year in which they are payable to the schemes.

	Other accounting policies
	Coronavirus bounce back loan scheme Being a government backed guaranteed bank loan with an interest rate of 2.5% commencing 12 months from the date of the loan. The finance element is charged to the profit and loss account calculated on the outstanding balance and the amount paid.

Employees
	2025	2024
Average number of employees during the period	19	20

Intangible fixed assets
	Other	Total
Cost	£	£
At 1 April 2024	52,202	52,202
Additions	2,264	2,264
At 31 March 2025	54,466	54,466
Amortisation
At 1 April 2024	23,411	23,411
Provided during the period	5,112	5,112
At 31 March 2025	28,523	28,523
Net book value
At 31 March 2025	25,943	25,943
At 31 March 2024	28,791	28,791

Tangible fixed assets
	Office equipment	Vehicles	Plant & machinery	Total
Cost or valuation	£	£	£	£
At 1 April 2024	26,390	15,193	518,797	560,380
Additions	133	0	848	981
Disposals	(3,752)	(0)	(0)	(3,752)
At 31 March 2025	22,771	15,193	519,645	557,609
Depreciation
At 1 April 2024	22,639	14,336	475,852	512,827
Charge for the period	1,272	214	10,947	12,433
On disposals	(3,752)	(0)	(0)	(3,752)
At 31 March 2025	20,159	14,550	486,799	521,508
Net book value
At 31 March 2025	2,612	643	32,846	36,101
At 31 March 2024	3,751	857	42,945	47,553

Share capital
	2025	2024
	£	£
Allotted, called up and fully paid:
2,300 (2024: 2,300) A Ordinary shares of £1.00 each	2,300	2,300

Allotted, called up and fully paid:
2,550 (2024: 2,550) B Ordinary shares of £1.00 each	2,550	2,550

Allotted, called up and fully paid:
150 (2024: 150) C Ordinary shares of £1.00 each	150	150

	5,000	5,000

	Commitments, guarantees and contingencies
	Notes Pension commitments The company operates a defined contribution pension scheme on behalf of its directors. The assets of the scheme are held separately from those of the company in an independently administered fund. There were no contributions paid by the company to the fund in the year (2024 - Nil). The company operates a defined contribution Automatic enrolment pension scheme on behalf of the employees. The assets of the scheme are held separately from those of the company in an independently administered fund. The annual pension commitment is for contributions of 3% (2024 - 3%) of pensionable earnings for the employees in the Automatic enrolment scheme. Lease commitments At the 31 March 2025 the company had annual commitments of £62500 (2024 - £62500) under non-cancellable operating leases and an annual commitment of £11193 (2024 - £17566) under non cancellable finance leases. At 31 March 2025 the company had annual commitments under a bounce back loan of £10000 (2024- £10000 ). The company does not consider the difference between the actual interest rate and the market rate for a similar debt instrument to be material being a rate of 2.5% per annum. Capital and other financial commitments and contingent liabilities The company did not have any capital or other financial commitments and contingent liabilities at 31 March 2025 (2024 - Nil).

Commitments, guarantees and contingencies

Notes

Pension commitments The company operates a defined contribution pension scheme on behalf of its directors. The assets of the scheme are held separately from those of the company in an independently administered fund. There were no contributions paid by the company to the fund in the year (2024 - Nil). The company operates a defined contribution Automatic enrolment pension scheme on behalf of the employees. The assets of the scheme are held separately from those of the company in an independently administered fund. The annual pension commitment is for contributions of 3% (2024 - 3%) of pensionable earnings for the employees in the Automatic enrolment scheme. Lease commitments At the 31 March 2025 the company had annual commitments of £62500 (2024 - £62500) under non-cancellable operating leases and an annual commitment of £11193 (2024 - £17566) under non cancellable finance leases. At 31 March 2025 the company had annual commitments under a bounce back loan of £10000 (2024- £10000 ). The company does not consider the difference between the actual interest rate and the market rate for a similar debt instrument to be material being a rate of 2.5% per annum. Capital and other financial commitments and contingent liabilities The company did not have any capital or other financial commitments and contingent liabilities at 31 March 2025 (2024 - Nil).

7.	Other information
	MJS Healthcare Limited is a private company limited by shares and incorporated in England and Wales. Its registered office is 310-312 Dallow Road, Luton, Bedfordshire LU1 1TD. The financial statements are presented in Sterling, which is the functional currency of the company. At 31 March 2025 Christopher J. Saggers, the sole director of the company, controlled the company as he owned all of the issued ordinary share capital. The principal activities of the company in the year under review was those of the design, manufacture and marketing of medical products.

Other information

MJS Healthcare Limited is a private company limited by shares and incorporated in England and Wales.
Its registered office is 310-312 Dallow Road, Luton, Bedfordshire LU1 1TD.

The financial statements are presented in Sterling, which is the functional currency of the company.

At 31 March 2025 Christopher J. Saggers, the sole director of the company, controlled the company as he owned all of the issued ordinary share capital.

The principal activities of the company in the year under review was those of the design, manufacture and marketing of medical products.